Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Small Cell Lung Carcinoma 8Carcinoma, Non-Small-Cell Lung 7Sarcoma 3Thyroid Neoplasms 2Nasopharyngeal Carcinoma 2Lung Neoplasms 2Esophageal Squamous Cell Carcinoma 2Carcinoma, Renal Cell 2Carcinoma, Hepatocellular 2Breast Neoplasms 2Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Cancer Extensive Stage 1Proteinuria 1Platinum-resistant Ovarian Cancer (PROC) 1Pheochromocytoma 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Osteosarcoma 1Neoplasms 1Neoplasm Metastasis 1NSCLC 1Melanoma 1Limited Stage Small Cell Lung Cancer 1Fallopian Tube Neoplasms 1Extensive Stage Lung Small Cell Cancer 1Esophageal Neoplasms 1Endometrial Neoplasms 1Carcinoma, Ovarian Epithelial 1

Interventions

Paclitaxel 4Topotecan 3liposomal doxorubicin 2Carboplatin 2irinotecan sucrosofate 1fluzoparib 1anlotinib 1Surgical Procedures, Operative 1Specimen Handling 1Poly A 1Neoadjuvant Therapy 1Magnetic Resonance Spectroscopy 1Losartan 1Gemcitabine 1Drug Therapy 1Doxorubicin 1Bevacizumab 1Angiogenesis Inhibitors 1Albumin-Bound Paclitaxel 1Adenosine Diphosphate Ribose 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Fallopian Tube Neoplasms × anlotinib × Clear all
NCT07489300 2026-03-24

BACON

Second Affiliated Hospital, School of Medicine, Zhejiang University

Phase 2 Not yet recruiting
40 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡